Association of Prohepcidin and Hepcidin-25 with Erythropoietin Response and Ferritin in Hemodialysis Patients
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Hepcidin is a key regulator of iron metabolism. In this study, we examined whether measurement of hepcidin is useful in assessing recombinant human erythropoietin (rHuEPO) responsiveness in regular hemodialysis (HD) patients in a cross-sectional fashion. We examined the association between serum prohepcidin, a prohormone of hepcidin, and rHuEPO dosage and the rHuEPO/hemoglobin (Hb) ratio in 75 HD patients. We also semiquantatively measured the peak intensity of serum hepcidin-25, the major form of mature hepcidin, in 24 HD patients by using surface-enhanced laser desorption ionization time of flight time mass spectrometry, and compared those between rHuEPO-hyporesponsive (rHuEPO 192 ± 10 [126–252] IU/kg/week, n = 15) and responsive patients (rHuEPO 40 ± 9 [0–81] U/kg/week, n = 9). A significant but weak relationship was found between serum prohepcidin and rHuEPO dosage (r = 0.24, p < 0.05) and rHuEPO/Hb ratio (r = 0.22, p = 0.06). However, prohepcidin did not become an indicator of hematopoietic parameters by multiple regression analysis. Serum hepcidin-25 intensity was significantly and positively correlated with ferritin (r = 0.51, p < 0.01) but not with log-transformed C-reactive protein. There was no difference in the intensities of serum hepcidin-25 between rHuEPO-hyporesponsive and responsive patients (64 ± 10 vs. 52 ± 16 AU, p = NS). It follows from these findings that the assessment of serum hepcidin using currently available assays was not valid in predicting rHuEPO responsiveness in chronic HD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 1×
“Hepcidin is expressed as an 84-amino acid (AA) pre-propeptide in hepatocytes, renal epithelial cells, and other several tissues. Cleavage of the 24-AA peptide produces a 60-AA residue prohormone, prohepcidin (molecular weight 10 kDa). Additional processing of the 34-AA pro region results in 25-, 22- and 20-AA peptides…”
BackgroundHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Hepcidin was originally discovered in studies searching for cationic antimicrobial peptides in human serum and urine [”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Severe iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860 · cited 1×
“In humans, mutations of the hepcidin gene are known to be implied in a severe iron overload disease such as juvenile hemochromatosis [”
BackgroundWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632 · cited 1×
“Inappropriately high expression of hepcidin is associated with iron-refractory anemia in patients with large hepatic adenomas [”
BackgroundTime-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS
Kemna, E., Pickkers, P., Nemeth, E., van der Hoeven, H., & Swinkels, D. (2005) · Blood · doi:10.1182/blood-2005-03-1159 · Cited by 498
Gunnell, J., Yeun, J. Y., Depner, T. A., & Kaysen, G. A. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70259-3 · Cited by 305
Kulaksiz, H., Theilig, F., Bachmann, S., Gehrke, S. G., Rost, D., Janetzko, A., Cetin, Y., & Stremmel, W. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05729 · Cited by 241 · cited 1×
“An increase in serum prohepcidin was also demonstrated in HD patients [”
Background
Cited by
Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
Zaritsky, J., Young, B., Wang, H.-J., Westerman, M., Olbina, G., Nemeth, E., Ganz, T., Rivera, S., Nissenson, A. R., & Salusky, I. B. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05931108 · Cited by 350
Iron Deficiency Anemia in Chronic Kidney Disease
Gafter-Gvili, A., Schechter, A., & Rozen-Zvi, B. (2019) · Acta Haematologica · doi:10.1159/000496492 · Cited by 265
Hepcidin in Human Iron Disorders: Diagnostic Implications
Kroot, J. J., Tjalsma, H., Fleming, R. E., & Swinkels, D. W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2009.140053 · Cited by 246
Reduction of serum hepcidin by hemodialysis in pediatric and adult patients
Zaritsky, J., Young, B., Gales, B., Wang, H.-J., Rastogi, A., Westerman, M., Nemeth, E., Ganz, T., & Salusky, I. B. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08161109 · Cited by 107
Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI)
Sasu, B. J., Li, H., Rose, M. J., Arvedson, T. L., Doellgast, G., & Molineux, G. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.07.013 · Cited by 43
Metadata
- Authors
- Kato, A., Tsuji, T., Luo, J., Sakao, Y., Yasuda, H., & Hishida, A.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2007-10-17
- Volume
- 28
- Issue
- 1
- Pages
- 115-121
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W2057547812
- Cited by
- 109
- References
- 10
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of Prohepcidin and Hepcidin-25 with Erythropoietin Response and Ferritin in Hemodialysis Patients. https://app.cochat.ai/papers/10.1159/000109968
- The paper
- Kato, A., Tsuji, T., Luo, J., Sakao, Y., Yasuda, H., & Hishida, A. (2008). Association of Prohepcidin and Hepcidin-25 with Erythropoietin Response and Ferritin in Hemodialysis Patients. American Journal of Nephrology. https://doi.org/10.1159/000109968
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.